Skip to content

Author

Yun-Feng Li

We have 3 of 177 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery

G protein-coupled receptors (GPCRs) constitute the largest druggable superfamily of membrane proteins and underlie approximately 35% of all approved medicines. Yet this conventional paradigm leaves a substantial minority of neuropsychiatric patients with incomplete efficacy, treatment resistance, or dose-limiting adver...

Peng Ren, Yun-Feng Li, Jing-Ya Wang · 0 citations
Open access Jul 2026

Antidepressant-like effects of ketamine involve CX3CL1/CX3CR1 signaling-mediated synaptic plasticity in the mPFC.

Ketamine, a non-competitive N-methyl-D-aspartate acid (NMDA) receptor antagonist, produces rapid and sustained antidepressant actions, but the underlying molecular mechanism remains unclear. The CX3CL1/CX3CR1 signaling is closely related to mood disorders, and this study aims to investigate its role in ketamine's antid...

Yong-Yu Yin, Si-Rui Sun, Hui-Ying Zhang et al. · 0 citations
Jul 2026

Activation of sigma non-opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive-like behaviours in mice.

Analysis demonstrated that overexpressing Plxdc2 in mPFC microglia activated the JAK2-STAT1 pathway, enhanced NLG, shifting microglia towards a pro-inflammatory phenotype, worsening deficits in synaptic plasticity and induced depressive-like behaviour, which was reversible by the NLG inhibitor tunicamycin.

Jing-ya Wang, Peng Ren, De-Yi Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.